Former Rep. Mimi Walters argues that Washington must prioritize domestic biomedical research and stricter regulatory oversight to counter China's rising influence and protect American patient safety.
Source: [The Hill](https://thehill.com/opinion/healthcare/6025864-china-biotech-safety-concerns/)